ICAAC

50_ICAAC_logo

Meet us at the 50th ICAAC in Boston, September 12-15th.

Booth number 811.

 

NDM-1

Check-Points introduces the first commercial assays to detect NDM-1.

Check-MDR CT101 detects carbapenemases (KPC and NDM-1), ESBLs and AmpCs.

Check-MDR CT102 detects the full range of clinically relevant carbapenemases (including KPC and NDM-1) in addition to ESBLs.

Learn more

Publications

Our first two products in the antibiotic resistance product range, Check-ESBL and Check-KPC ESBL, were introduced in 2009. They have been extensively evaluated by leading experts in Europe and the USA:

Learn more

Check&Trace Salmonella

Salmonella serotyping plays an essential role in any Salmonella reduction program.

To combat foodborne diseases and to reduce Salmonella contaminations considerably, Check&Trace Salmonella allows you to detect and identify Salmonella Serotypes in one reliable routine test.

Learn more
Check-Points, Life Sciences

Check-Points develops diagnostic products for specific applications for everyday use in clinics, institutes and companies, based on their innovative Check-Made system. 

Check-Made combines a highly efficient multiplex amplification method with a simple, user-friendly diagnostic microarray detection system.

Rapid Molecular Detection of Carbapenemases, AmpC and ESBL

Check-Points is the first company to introduce rapid molecular tests with the highest sensitivity and specificity for Carbapenemases, AmpC and ESBL for each hospital.

Rapid and accurate confirmation of antibiotic resistance is crucial for the management of critical infections, especially among intensive care patients. read more

Clinical Relevance

Antibiotic resistance in gram negative bacteria has quickly become an important issue in hospitals.

Year after year, both the number of affected patients as well as the complexity of the hospital acquired infections increase significantly. read more